FDA approves first generics of Gilenya - FDA Press Releases

The U.S. Food and Drug Administration today approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients

from FDA Press Releases RSS Feed https://ift.tt/33Ved6a
via IFTTT